Luyuan Ma, An Xu, Lei Kang, Rui Cong, Zhongyi Fan, Xiang Zhu, Nan Huo, Wenpeng Liu, Chunyuan Xue, Quanbo Ji, Wenchao Li, Zhong Chu, Xiaofeng Kang, Yadong Wang, Zhijia Sun, Yuchen Han, Hanxiao Liu, Xiang Gao, Juqiang Han, Hua You, Caiyan Zhao, Xiaojie Xu – 28 July 2021
Takeshi Suda, Seiichi Yoshikawa, Tsutomu Kanefuji, Satoshi Abe, Takahiro Hoshi, Shinichi Morita, Kazuyoshi Yagi, Shuji Terai – 28 July 2021
Kishor Pant, Estanislao Peixoto, Seth Richard, Aalekhya Biswas, M. Gerard O’Sullivan, Nasra Giama, Yeonjung Ha, Jun Yin, Pietro Carotenuto, Massimiliano Salati, Yanan Ren, Rendong Yang, Brunella Franco, Lewis R. Roberts, Sergio A. Gradilone – 28 July 2021
Zechuan Zhang, Zetao Ji, Jianbo He, Yijun Lu, Wenfang Tian, Chang Zheng, Huihui Chen, Quan Zhang, Fei Yang, Minglu Zhang, Yin Yin, Runqiu Jiang, Wen‐Ming Chu, Wenjie Zhang, Beicheng Sun – 28 July 2021
Sonal Kumar, Rochelle Wong, Carolyn Newberry, Michele Yeung, Jessica M. Peña, Reem Z. Sharaiha – 28 July 2021
Annika Volmari, Katharina Foelsch, Elisabeth Zierz, Karsten Yan, Minyue Qi, Karlotta Bartels, Stephanie Kondratowicz, Marius Boettcher, Daniel Reimers, Masahiro Nishibori, Keyue Liu, Robert F. Schwabe, Ansgar W. Lohse, Samuel Huber, Hans‐Willi Mittruecker, Peter Huebener – 27 July 2021 – High‐mobility group box 1 (HMGB1) is a nucleoprotein with proinflammatory functions following cellular release during tissue damage.
Pengcheng Cai, Xiaoyu Mao, Jieqiong Zhao, Li Nie, Yan Jiang, Qifen Yang, Rui Ni, Jianbo He, Lingfei Luo – 27 July 2021
Jingjing Song, Yupeng Liu, Juan Wan, Guang‐Nian Zhao, Jian‐Cheng Wang, Zhifei Dai, Sha Hu, Ling Yang, Zhen Liu, Yi Fu, Erdan Dong, Yi‐Da Tang – 27 July 2021
Masaru Muraoka, Shinya Maekawa, Ryo Katoh, Yasuyuki Komiyama, Natsuko Nakakuki, Hitomi Takada, Shuya Matsuda, Yuichiro Suzuki, Mitsuaki Sato, Akihisa Tatsumi, Mika Miura, Fumitake Amemiya, Hiroko Shindo, Shinichi Takano, Mitsuharu Fukasawa, Kozue Yamauchi, Tatsuya Yamaguchi, Yasuhiro Nakayama, Taisuke Inoue, Nobuyuki Enomoto – 27 July 2021 – Although the usefulness of liquid biopsy as a biomarker in the treatment of hepatocellular carcinoma (HCC) has been suggested, its usefulness in transcatheter arterial chemoembolization (TACE) or tyrosine kinase inhibitor (TKI) therapies has not been re
Adam E. Mikolajczyk, Netanel Zilberstein, John F. McConville, Alex Pan, Andrew I. Aronsohn, Helen S. Te, Gautham Reddy, Sonali Paul, Anjana Pillai, Michael Charlton, Jeanne M. Farnan – 27 July 2021 – We previously created a mandatory, inpatient, hepatology resident curriculum that immediately improved comfort, knowledge, and career interest in chronic liver disease (CLD). The durability of these effects needs to be known to use this intervention to address the hepatologist shortage.